<strong>Bdf-Gestion</strong> Q2 2026: Major Increases and Decreases Observed

Bdf-Gestion significantly boosted its positions in several technology and healthcare stocks during Q2 2026, while reducing holdings or exiting others.

By Insiderset.Jul 9, 2026, 9:59 AM
<strong>Bdf-Gestion</strong> Q2 2026: Major Increases and Decreases Observed

Bdf-Gestion, a significant investor with substantial portfolio movements observed as of June 30th, 2026.

This quarter saw notable changes across various sectors. The most striking activity involved large increases in specific positions:

The observed buying activities primarily targeted companies like KLA Corp, Neurocrine Biosciences, Marvell Technology, Stamps.com, and General Electric. These additions suggest confidence in these specific sectors or individual company prospects.

Conversely, the selling or reduction activities were prominent across other technology giants (NVIDIA, Apple, Microsoft, AT&T) and included an exit from ServiceNow as well as a divestment of Honeywell International shares. This indicates a strategic shift away from these specific large-cap names.

Furthermore, Bdf-Gestion maintained its position in Tenet Healthcare Corp (THC), which saw no change in the number of shares held during this period.

<strong>Bdf-Gestion</strong> Q2 2026: Major Increases and Decreases Observed | InsiderSet